Novo Nordisk flags near-term headwinds in global markets
Danish pharmaceutical giant Novo Nordisk signals upcoming challenges in international markets. Get the latest business insights and analysis on this developing story.
Danish pharmaceutical giant Novo Nordisk signals upcoming challenges in international markets. Get the latest business insights and analysis on this developing story.
Citeline and Risklick partner to transform clinical trial design with AI, aiming to reduce costly amendments and accelerate drug development timelines for Canadian researchers.
Nvidia commits $1 billion to a joint AI laboratory with pharmaceutical giant Eli Lilly, aiming to automate and accelerate drug discovery. The Silicon Valley facility will bridge AI and lab science.
The CEO of Novo Nordisk disclosed that an estimated 1.5 million Americans are using compounded versions of GLP-1 drugs. Learn about the market implications and safety concerns.
PrimeFab is hosting a manufacturing job fair in Midland, Ontario, to recruit talent for its home construction projects. Learn about the opportunities and how to apply.
A British Columbia woman is calling on the provincial government to fund a new multiple sclerosis drug. Her plea highlights the critical gap in coverage for patients.
Pharmaceutical giant Novo Nordisk is considering a strategic rebrand of a lower-price version of Ozempic to compete directly with upcoming generic alternatives. Learn about the potential market shift.
A Canadian manufacturing expert argues AI will augment, not replace, factory jobs in 2026. Learn why fears of widespread automation-driven unemployment may be misplaced.
Dr. Sue Pedersen advises patients to consult their doctors individually about using generic or brand-name Ozempic. A pivotal moment for diabetes and weight-loss treatment access in Canada.
Canadian companies can begin producing generic versions of Ozempic starting next week, but experts warn patients should not expect immediate access due to manufacturing and distribution timelines.
Health Canada enforcement officers have seized unauthorized pharmaceutical drugs from a Vancouver fitness facility. Discover the details of the raid and the ongoing risks of unregulated substances.
U.S. regulators have greenlit a pill version of a leading weight-loss medication, potentially broadening treatment options. Learn about the approval and its implications.
U.S. regulators have approved the Wegovy pill for weight loss, a major development in pharmaceutical treatment. Learn about the details and potential impact of this new drug.
A Fox News anchor delivered a brutal math lesson on air, highlighting the impossibility of Trump's claim about slashing prescription drug prices by 600%. See the reality vs. perception clash unfold.
Health Canada has granted approval for a new pharmaceutical treatment targeting a rare disease, offering hope for patients. Learn about the regulatory decision and its impact.
Pfizer projects 2026 profits below Wall Street estimates due to a steep drop in COVID product sales and loss of exclusivity for key drugs. Get the full business analysis.
The first 2026 Dodge Charger Scat Pack has been built at the Windsor Assembly Plant. Get the details on this milestone for Canadian auto manufacturing.
China's biopharma industry is accelerating, fueled by record investment and streamlined supply chains. With faster development times and massive deals like AstraZeneca's $5.2B pact, the global drug innovation race is heating up. Discover the shift from ou
Explore the stark contrast between booming St. Thomas and struggling Ingersoll as the auto industry's electric vehicle transition reshapes Southwestern Ontario's economic landscape.
Algoma Steel is cutting 40% of its workforce, citing U.S. tariffs and a forced shift to electric arc steelmaking. The layoffs come just two weeks after a major government bailout.
Algoma Steel announces 1,000 layoffs in Sault Ste. Marie, citing difficult market conditions and trade pressures. Read about the impact and federal support.
Workers at the Diageo bottling plant in Amherstburg, Ontario, have ratified a closure agreement. The deal finalizes the shuttering of the facility, impacting hundreds of local jobs. Learn the details and implications for the community.
Pharmaceutical giant Eli Lilly has reduced the price of its obesity medication Zepbound to improve patient access. The move comes amid growing demand for GLP-1 drugs in Canada and globally.
Boehringer Ingelheim announces Harsha Deshmukh's appointment to Board of Managing Directors for IT and Global Business Services effective February 2026.
Grey Bruce residents exchanged unused pharmaceuticals for Barrie Colts hockey tickets in a successful medication safety initiative. Learn how this program helps combat opioid misuse and environmental contamination.
Dipharma publishes a peer-reviewed study unveiling a novel method to detect and characterize nitrosamine impurities in Active Pharmaceutical Ingredients, enhancing drug safety and regulatory compliance.
Canada's steel sector welcomes new federal support measures while calling for an end to the tariff remission program. Industry leaders seek competitive balance.
Canadian steel executive Barry Zekelman praises federal government's decision to claw back imported steel, calling it vital for domestic manufacturing sector and job protection.
Campbell's Soup Company forcefully responds to what it calls an 'absurd' charge regarding the use of 3D-printed chicken in its products. Get the full story on this developing news.
Prime Minister Mark Carney will unveil protective measures for Canada's steel and softwood lumber sectors this Wednesday. Learn how this impacts trade and jobs.